IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR METHYLPREDNISOLONE AND MEDROXYPROGESTERONE

  • The National Reporting and Learning System database has received several reports detailing
    errors from miss-selection relating to Depo-Provera® (medroxyprogesterone), Depo-Medrone® (methylprednisolone) and Depo-Medrone with Lidocaine® (methylprednisolone/lidocaine).
  • Confusion seems to arise from similar looking brand and generic names as well as similar
    packaging. The UKMi product assessment tool was used to see if in fact this was an important
    factor.
  • In the process of carrying out this assessment, two further products (Sayana Press®
    (medroxyprogesterone) and Solu-Medrone® (methylprednisolone)) were found to have the
    potential to cause error and have therefore been included in this assessment.
MedroxyprogesteroneMethylprednisoloneMethylprednisolone + LidocaineNew MedicinesPrimary Care

Attachments